Equities

Evofem Biosciences Inc

Evofem Biosciences Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.41
  • Today's Change0.015 / 3.77%
  • Shares traded6.32m
  • 1 Year change-84.93%
  • Beta-0.2475
Data delayed at least 15 minutes, as of Jan 14 2022 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • EVFM:NAQ trading volume exceeds daily average by +257.85%
  • EVFM:NAQ price moved over +20.95% to 0.47
  • EVFM:NAQ price rises above 50-day moving average to 0.48 at 09:30 GMT
  • EVFM:NAQ price rises above 15-day moving average to 0.40 at 09:30 GMT
  • EVFM:NAQ price falls below 15-day moving average to 0.3977 at 10:18 GMT
  • EVFM:NAQ price rises above 15-day moving average to 0.47 at 09:30 GMT

Key statistics

On Friday, Evofem Biosciences Inc (EVFM:NAQ) closed at 0.41, 13.89% above the 52 week low of 0.36 set on Jan 10, 2022.
52-week range
Today
0.36Jan 10 20225.53Feb 17 2021
Markit short selling activity
Low
Med
High
Open0.3903
High0.43
Low0.387
Bid0.4001
Offer0.4098
Previous close0.3951
Average volume7.46m
Shares outstanding162.50m
Free float161.61m
P/E (TTM)--
Market cap66.63m USD
EPS (TTM)-1.81
USD
Data delayed at least 15 minutes, as of Jan 14 2022 21:00 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.